Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob George

Showing results (661-670 of 849) with videos related to

Pageof 85
Sort By:
Diabetes Research and Clinical Practice|August 11, 2023
The first external validation of the Dallas steatosis index in biopsy-proven Non-alcoholic fatty liver Disease: A multicenter studyMatina Kouvari, Sophia C Mylonakis, Angeliki Katsarou, et al.
Hepatology (Baltimore, Md.)|August 31, 2010
Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infectionJason Grebely, Kathy Petoumenos, Margaret Hellard, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 1, 2015
Interferon-free regimens containing setrobuvir for patients with genotype 1 chronic hepatitis C: a randomized, multicenter studyDonald M Jensen, Michael Brunda, Robert Elston, et al.
Liver Cancer|March 6, 2023
Discriminatory Changes in Circulating Metabolites as a Predictor of Hepatocellular Cancer in Patients with Metabolic (Dysfunction) Associated Fatty Liver DiseaseHaonan Lu, Jacob George, Mohammed Eslam, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 26, 2016
Maximum levels of hepatitis C virus lipoviral particles are associated with early and persistent infectionDavid A Sheridan, Behzad Hajarizadeh, Fiona I Fenwick, et al.
Cell Systems|May 6, 2021
Core liver homeostatic co-expression networks are preserved but respond to perturbations in an organism- and disease-specific mannerSaeed Esmaili, Peter Langfelder, T Grant Belgard, et al.
Hepatology (Baltimore, Md.)|September 22, 2012
Hepatic fat loss in advanced nonalcoholic steatohepatitis: are alterations in serum adiponectin the cause?David van der Poorten, Caroline F Samer, Mehdi Ramezani-Moghadam, et al.
Cardiovascular Diabetology|December 3, 2022
Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease preventionXiao-Dong Zhou, Jingjing Cai, Giovanni Targher, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 9, 2021
Opportunities to Enhance Linkage to Hepatitis C Care Among Hospitalized People With Recent Drug Dependence in New South Wales, Australia: A Population-based Linkage StudyHeather Valerio, Maryam Alavi, Matthew Law, et al.
Journal of Hepatology|March 26, 2019
KLRG1+ natural killer cells exert a novel antifibrotic function in chronic hepatitis BRatna S Wijaya, Scott A Read, Stephen Schibeci, et al.
Pageof 85

Showing results (661-670 of 849) with videos related to

Sort By:
Pageof 85
Diabetes Research and Clinical Practice|August 11, 2023
The first external validation of the Dallas steatosis index in biopsy-proven Non-alcoholic fatty liver Disease: A multicenter studyMatina Kouvari, Sophia C Mylonakis, Angeliki Katsarou, et al.
Hepatology (Baltimore, Md.)|August 31, 2010
Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infectionJason Grebely, Kathy Petoumenos, Margaret Hellard, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 1, 2015
Interferon-free regimens containing setrobuvir for patients with genotype 1 chronic hepatitis C: a randomized, multicenter studyDonald M Jensen, Michael Brunda, Robert Elston, et al.
Liver Cancer|March 6, 2023
Discriminatory Changes in Circulating Metabolites as a Predictor of Hepatocellular Cancer in Patients with Metabolic (Dysfunction) Associated Fatty Liver DiseaseHaonan Lu, Jacob George, Mohammed Eslam, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 26, 2016
Maximum levels of hepatitis C virus lipoviral particles are associated with early and persistent infectionDavid A Sheridan, Behzad Hajarizadeh, Fiona I Fenwick, et al.
Cell Systems|May 6, 2021
Core liver homeostatic co-expression networks are preserved but respond to perturbations in an organism- and disease-specific mannerSaeed Esmaili, Peter Langfelder, T Grant Belgard, et al.
Hepatology (Baltimore, Md.)|September 22, 2012
Hepatic fat loss in advanced nonalcoholic steatohepatitis: are alterations in serum adiponectin the cause?David van der Poorten, Caroline F Samer, Mehdi Ramezani-Moghadam, et al.
Cardiovascular Diabetology|December 3, 2022
Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease preventionXiao-Dong Zhou, Jingjing Cai, Giovanni Targher, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 9, 2021
Opportunities to Enhance Linkage to Hepatitis C Care Among Hospitalized People With Recent Drug Dependence in New South Wales, Australia: A Population-based Linkage StudyHeather Valerio, Maryam Alavi, Matthew Law, et al.
Journal of Hepatology|March 26, 2019
KLRG1+ natural killer cells exert a novel antifibrotic function in chronic hepatitis BRatna S Wijaya, Scott A Read, Stephen Schibeci, et al.
Pageof 85